TITLE:
Evaluation of Treatment Outcomes in Pregnant Women Infected with COVID-19: A Retrospective Analysis
AUTHORS:
Ravshan Aliyevich Ibadov, Khilola Pulatovna Alimova, Tatyana Valerievna Tyan, Sardor Khamdamovich Ibragimov
KEYWORDS:
COVID-19, Pregnancy, Maternal Outcomes, SARS-CoV-2 Variants, Preterm Birth, Uteroplacental Insufficiency, Respiratory Support, Intensive Care, Maternal Outcomes
JOURNAL NAME:
Open Journal of Emergency Medicine,
Vol.13 No.1,
January
21,
2025
ABSTRACT: This study aimed to analyze maternal outcomes in pregnant women infected with COVID-19, focusing on the impact of disease severity, timing of medical intervention, and the effect of different SARS-CoV-2 variants. A retrospective analysis was conducted on 9,288 pregnant women diagnosed with COVID-19. Disease severity was classified as mild (30%), moderate (52%), severe (17%), and critical (2%). The study also examined the timing of medical care, with 41.6% of women seeking care within 7 days of symptom onset and 58.4% after 7 days. The average gestational age was 271.8 days, with the majority (93.8%) at full-term pregnancy. Results indicated that 88.2% of women continued their pregnancies during treatment, while 11.9% experienced pregnancy termination, including preterm deliveries and miscarriages. The study found a significant (p